Itron, Inc. (NASDAQ:ITRI – Get Free Report) SVP Christopher Ware sold 189 shares of Itron stock in a transaction on Wednesday, May 20th. The shares were sold at an average price of $79.60, for a total value of $15,044.40. Following the completion of the transaction, the senior vice president owned 30,506 shares of the company’s stock, valued at approximately $2,428,277.60. This trade represents a 0.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Itron Price Performance
Shares of NASDAQ ITRI opened at $83.02 on Friday. The stock has a market cap of $3.68 billion, a PE ratio of 13.24, a price-to-earnings-growth ratio of 0.73 and a beta of 1.35. Itron, Inc. has a fifty-two week low of $77.77 and a fifty-two week high of $142.00. The company has a debt-to-equity ratio of 0.97, a quick ratio of 2.24 and a current ratio of 2.66. The stock has a fifty day moving average of $88.45 and a 200-day moving average of $94.52.
Itron (NASDAQ:ITRI – Get Free Report) last announced its quarterly earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.23. The company had revenue of $586.98 million during the quarter, compared to analysts’ expectations of $572.04 million. Itron had a return on equity of 19.54% and a net margin of 12.31%.The firm’s quarterly revenue was down 3.3% compared to the same quarter last year. During the same period in the previous year, the business earned $1.52 earnings per share. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. Equities research analysts anticipate that Itron, Inc. will post 6.01 earnings per share for the current year.
Key Itron News
- Positive Sentiment: Stephens reiterated an Overweight rating on Itron and kept a $130 price target, signaling substantial upside versus recent trading levels.
- Neutral Sentiment: Several Itron executives sold small amounts of stock, but the filings say the shares were sold mainly to cover tax withholding tied to equity award vesting, which makes the insider activity look routine rather than a major red flag.
- Negative Sentiment: Zacks Research cut multiple future earnings estimates for Itron, including a sharp reduction to Q4 2027 EPS and a lower FY2027 outlook, suggesting softer profit growth ahead.
Institutional Investors Weigh In On Itron
Several hedge funds have recently added to or reduced their stakes in ITRI. Private Trust Co. NA lifted its stake in Itron by 112.4% during the fourth quarter. Private Trust Co. NA now owns 274 shares of the scientific and technical instruments company’s stock worth $25,000 after purchasing an additional 145 shares during the last quarter. Employees Retirement System of Texas bought a new stake in Itron during the third quarter worth about $32,000. Optiver Holding B.V. bought a new stake in Itron during the third quarter worth about $36,000. Northwestern Mutual Wealth Management Co. lifted its stake in Itron by 29.5% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 443 shares of the scientific and technical instruments company’s stock worth $41,000 after purchasing an additional 101 shares during the last quarter. Finally, Aster Capital Management DIFC Ltd bought a new stake in Itron during the third quarter worth about $44,000. Institutional investors own 96.19% of the company’s stock.
Wall Street Analyst Weigh In
Several equities research analysts recently issued reports on ITRI shares. Needham & Company LLC started coverage on Itron in a research note on Friday, March 6th. They set a “buy” rating and a $124.00 price objective for the company. TD Cowen dropped their price objective on Itron from $145.00 to $130.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. Oppenheimer lifted their price objective on Itron from $133.00 to $135.00 and gave the company an “outperform” rating in a research note on Thursday, April 16th. Robert W. Baird set a $128.00 price objective on Itron and gave the company an “outperform” rating in a research note on Wednesday, February 18th. Finally, Stephens reissued an “overweight” rating and set a $130.00 price objective on shares of Itron in a research note on Wednesday. Eight investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Itron has a consensus rating of “Moderate Buy” and a consensus price target of $131.22.
View Our Latest Stock Analysis on Itron
About Itron
Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.
Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.
See Also
- Five stocks we like better than Itron
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.
